@deepsouthdoctor · Long SPRB

$SPRB - re-bought full position at $43. EV of ~ $30m, will file NDA this Q for rare disease drug. FDA interactions have been positive, and gets Priority Review Voucher if drug gets approved in indication with no approval. tx. Sales price of PRV worth > 1.5x current market cap.

Read asLong SPRB

Since the call—

unrankedThe analyst's rank today

High · 0.99Confidence

Wed, Oct 7Tweeted

Thu, Oct 8 closeCounted from

4% of the basket · day 12fades out by Nov 18

Rank per close

—

Oct 8

—

Oct 11

—

Oct 12

—

Oct 13

—

Oct 14

—

Oct 15

—

Oct 18

—

Oct 19